Home/Compounds/Pharmaceutical Intermediate/(23S,50S)-50-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
C64H101N5O16
1196.5 g/mol
Pharmaceutical Intermediate
(23S,50S)-50-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-23-(tert-butoxycarbonyl)-2,2-dimethyl-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
CAS1662688-20-1EC892-611-1
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate
This compound is a pharmaceutical intermediate specifically designed for peptide synthesis. It features a complex structure with multiple amide and ether linkages, protected by tert-butyl and fluorenylmethoxycarbonyl (Fmoc) groups, and is characterized by high molecular weight and lipophilicity.
peptide synthesis intermediateresearch compound for medicinal chemistry
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1662688-20-1
Related Compounds
StrongStructure SimilarSimilarity 1.00
FMOC-L-LYS[C20-OTBU-GLU(OTBU)-AEEA-AEEA]-OH
CAS2460751-66-8
research compound
StrongStructure SimilarSimilarity 1.00
(25S,43S)-43-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-25-(tert-butoxycarbonyl)-2,2-dimethyl-4,23,28,37-tetraoxo-3,32,35-trioxa-24,29,38-triazatetratetracontan-44-oic acid
CAS2612237-97-3
research compound
StrongStructure SimilarSimilarity 1.00
Fmoc-L-Lys[C20-OtBu-L-Glu(OtBu)-AA-AA]-OH
CAS2915356-76-0
pharmaceutical intermediate
StrongStructure SimilarSimilarity 0.87
Fmoc-Lys[|A-Glu(OtBu)-C18-OtBu)]-OH
CAS1931109-48-6
research compound
ApplicationSame Use
N-Boc-N'-Fmoc-L-ornithine
CAS150828-96-9
pharmaceutical intermediate
ApplicationSame Use
Boc-His(Trt)-Aib-OH
CAS2061897-68-3
pharmaceutical intermediate
ApplicationSame Use
(2S)-4-[[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid
CAS235788-61-1
pharmaceutical intermediate
ApplicationSame Use
Fmoc-AEEA-AEEA
CAS560088-89-3
pharmaceutical intermediate
Safety Reference
H413May cause long lasting harmful effects to aquatic life
Identifiers
IUPAC Name
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[2-[2-[2-[[2-[2-[2-[[(4S)-5-[(2-methylpropan-2-yl)oxy]-4-[[18-[(2-methylpropan-2-yl)oxy]-18-oxooctadecanoyl]amino]-5-oxopentanoyl]amino]ethoxy]ethoxy]acetyl]amino]ethoxy]ethoxy]acetyl]amino]hexanoic acid
InChIKey
COTQASXXEXJBOM-PJYGOTMFSA-N
SMILES
CC(C)(C)OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C(=O)OC(C)(C)C
Synonyms (12)
- Semaglutide Impurity 35